In This Article:
The United States market has shown positive momentum recently, with a 2.2% increase over the last week and an 8.2% climb in the past year, while earnings are projected to grow by 14% annually in the coming years. In this dynamic environment, identifying promising stocks often involves looking for companies with strong fundamentals and growth potential that may not yet be widely recognized by investors.
Top 10 Undiscovered Gems With Strong Fundamentals In The United States
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Wilson Bank Holding | NA | 7.87% | 8.22% | ★★★★★★ |
| Oakworth Capital | 42.08% | 15.43% | 7.31% | ★★★★★★ |
| Teekay | NA | -0.89% | 62.53% | ★★★★★★ |
| Solesence | 33.45% | 23.87% | -3.75% | ★★★★★★ |
| FineMark Holdings | 122.25% | 2.34% | -26.34% | ★★★★★★ |
| FRMO | 0.09% | 44.64% | 49.91% | ★★★★★☆ |
| Pure Cycle | 5.11% | 1.07% | -4.05% | ★★★★★☆ |
| First IC | 38.58% | 9.04% | 14.76% | ★★★★☆☆ |
| Reitar Logtech Holdings | 31.39% | 231.46% | 41.38% | ★★★★☆☆ |
| Qudian | 6.38% | -68.48% | -57.47% | ★★★★☆☆ |
We're going to check out a few of the best picks from our screener tool.
Nutex Health
Simply Wall St Value Rating: ★★★★★☆
Overview: Nutex Health Inc. is a physician-led healthcare services and operations company in the United States with a market cap of approximately $633.73 million.
Operations: Nutex Health generates revenue primarily from its Hospital Division, contributing $449.06 million, and its Population Health Management Division, adding $30.88 million.
Nutex Health, a small player in the healthcare sector, has shown significant financial improvement. Over the past year, it turned profitable with net income reaching US$52.18 million from a previous loss of US$45.79 million. The company's debt to equity ratio impressively dropped from 106.7% to 20% over five years, indicating better financial management. Nutex's interest payments are well covered by EBIT at 6.9 times coverage, and its price-to-earnings ratio of 13.8x suggests good value compared to the US market average of 17.5x. However, earnings are forecasted to decline by an average of 42.6% annually over the next three years despite revenue growth expectations at 8.55%. Recent auditor changes and shelf registration filings indicate active corporate governance and capital raising efforts respectively.
-
Dive into the specifics of Nutex Health here with our thorough health report.
-
Examine Nutex Health's past performance report to understand how it has performed in the past.
Graham
Simply Wall St Value Rating: ★★★★★★
Overview: Graham Corporation, along with its subsidiaries, specializes in designing and manufacturing fluid, power, heat transfer, and vacuum technologies for various industries including chemical processing, defense, space exploration, petroleum refining, cryogenics, and energy; it has a market cap of $361.11 million.
